Literature DB >> 8371142

Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys.

S S Negus1, E R Butelman, Y Al, J H Woods.   

Abstract

Four monkeys were seated in primate restraint chairs and the terminal 10 cm of their shaved tails were dipped into water maintained at a series of temperatures ranging from 38-54 degrees C. The latency to tail withdrawal from several temperatures was measured and temperature-effect curves for each monkey were generated. When administered s.c. into the tail, prostaglandin E2 (PGE2; 0, 1.58, 5.0 and 15.8 micrograms) produced a dose-dependent hyperalgesia manifested as dose-dependent leftward shifts in the temperature-effect curves. This hyperalgesia peaked 15 to 45 min after administration and lasted for approximately 2 hr. PGE2-induced hyperalgesia was mediated locally, because administration of 15.8 micrograms of PGE2 into the back had no effect on the temperature-effect curve. The hyperalgesic effects of PGE2 were reversed potently by morphine (0.32-3.2 mg/kg), and the effects of morphine were antagonized in a surmountable manner by both the opioid antagonist quadazocine (0.1 mg/kg) and by systemic administration of the charged opioid antagonist quaternary naltrexone (3.2 mg/kg). These results indicate that PGE2 produces thermal hyperalgesia in rhesus monkeys and also suggests that this hyperalgesia may be reversed by activation of peripheral opioid receptors. PGE2-induced hyperalgesia in the warm-water tail-withdrawal procedure may provide a useful assay for evaluating the effects of pharmacological and nonpharmacological treatments on hyperalgesia associated with inflammation in primates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371142

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception.

Authors:  M C Ko; N N Naughton
Journal:  Anesthesiology       Date:  2000-03       Impact factor: 7.892

2.  Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy.

Authors:  Matthew L Banks; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2010-07-30       Impact factor: 4.030

3.  A dose response study of the effect of prostaglandin E2 on thermal nociceptive sensitivity.

Authors:  Anthony F Domenichiello; Breanne C Wilhite; Gregory S Keyes; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-08-31       Impact factor: 4.006

4.  Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.

Authors:  Devki D Sukhtankar; Heeseung Lee; Kenner C Rice; Mei-Chuan Ko
Journal:  Psychopharmacology (Berl)       Date:  2013-11-12       Impact factor: 4.530

5.  Modulation of delta opioid agonist-induced antinociception by repeated morphine pretreatment in rhesus monkeys.

Authors:  S S Negus; M L Banks; J E Folk; K C Rice
Journal:  Life Sci       Date:  2010-01-21       Impact factor: 5.037

6.  The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys.

Authors:  M C Ko; E R Butelman; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

7.  Behavioral pharmacology of the mu/delta opioid glycopeptide MMP2200 in rhesus monkeys.

Authors:  Gail Pereira Do Carmo; Robin Polt; Edward J Bilsky; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2008-05-29       Impact factor: 4.030

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.